Glucose Transporter Type 1 Deficiency Syndrome

Explore clinical trials studying Glucose Transporter Type 1 Deficiency Syndrome. Study availability and eligibility vary by location and protocol.

8 public trials 1 recruiting study

Refine in advanced search Browse all conditions

Glucose Transporter Type 1 Deficiency Syndrome trial results

Recruiting

NCT05085704

Conditions: Brain Diseases, Central Nervous System Diseases, Epilepsy, +11 more
Locations: Weill Cornell Medicine New York, United States

UT Southwestern Medical Center Dallas, Texas, United States

Completed

NCT03181399

Conditions: Brain Diseases, Central Nervous System Diseases, Epilepsy, +11 more
Locations: University of Texas Southwestern Medical Center Dallas, Texas, United States

Completed

NCT02013583

Conditions: GLUT-1 Deficiency Syndrome, GLUT1 Deficiency Syndrome, Glucose Transporter Type 1 Deficiency Syndrome, +2 more
Locations: UT Southwestern Medical Center Dallas, Texas, United States

Completed

NCT02915211

Conditions: Brain Diseases, Central Nervous System Diseases, Drug Resistant Epilepsy, +6 more
Locations: Central Manchester University Hospitals NHS Foundation Trust Manchester, Greater Manchester, United Kingdom

Leeds Teaching Hospitals NHS Trust Leeds, West Yorkshire, United Kingdom

Completed

NCT04399954

Conditions: Brain Diseases, Central Nervous System Diseases, Drug Resistant Epilepsy, +6 more
Locations: Royal Aberdeen Children's Hospital Aberdeen, United Kingdom

Barberry Birmingham, United Kingdom

Bristol Royal Hospital for Children Bristol, United Kingdom

Leeds Children's Hospital Leeds, United Kingdom

Completed

NCT03041363

Conditions: Brain Diseases, Central Nervous System Diseases, Epilepsy, +11 more
Locations: UT Southwestern Medical Center Dallas, Texas, United States

Completed

NCT02018315

Conditions: GLUT1 Deficiency Syndrome, Glucose Transporter Type 1 Deficiency Syndrome, Glut1 Deficiency Syndrome
Locations: UT Southwestern Medical Center Dallas, Texas, United States

Active, Not Recruiting

NCT03655223

Conditions: 17 Alpha-Hydroxylase Deficiency, 3-Hydroxy-3-Methylglutaric Aciduria, 3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency, +456 more
Locations: RTI International Research Triangle Park, North Carolina, United States